Navigation Links
Grant Encourages Drug Testing Sans Animals

In order to restrict the use animals for the purpose of drug testing which is currently in vogue//, new techniques are being developed by researchers at the University of Manchester, well supported with a whopping 130,000£ as a financial grant.

Gauging the carcinogenic effects of new drugs are often fruitless using current parameters which further necessitates the use of live animals to establish their safety.

Gentronix , a research company founded by Dr Richard Walmsley and colleagues at the University, have developed techniques using cultured human cells to more effectively weed out cancer-causing compounds.

"The current pre-animal tests that are used are highly sensitive and so most carcinogens are identified," said Dr Walmsley, who is based in the Faculty of Life Sciences. "Unfortunately, such tests have poor specificity and a lot of safe compounds are also wrongly identified as potential carcinogens. This means that animal testing is still carried out, in case such compounds turn out to be safe. "The testing process developed at Gentronix has proven very reliable at telling us whether a drug will cause cancer but some chemicals, called promutagens, only become carcinogenic once they have passed through the body's liver.

"This grant will help us develop new non-animal experiments to identify these other toxic compounds and so reduce the need for animal testing."

The funding – awarded by the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) – will help the scientists establish new genotoxicity tests using cultured human liver cells. It is hoped the new test will not only reduce the number of compounds that are tested on animals but also ensure harmless chemicals that could prove to be useful new drugs are not falsely labeled as carcinogens.

"I don't believe that animal testing will disappear from drug safety assessment in the short term as you can't ask human volunteers to take novel drugs straight from testing done in tube tests," said Dr Walmsley.

"But if we can refine the pre-animal tests and increase people's confidence in them, then we will be able to reduce the number of chemicals that are tested on live animals."

Source-Eurekalert
MS
'"/>




Related medicine news :

1. Grant of $7 million for Orissa Medical College from Japan
2. Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program
3. $2.4 Million Grant To Unravel The Mystery Of Language Recognition.
4. Bail Granted To The Doctor Despite Her Patients Death
5. AIDS Funding Grants Dependant on Tracking Patients Names Efficiently
6. NGO Files Pre-Grant Opposition Against Anti-HIV Drug, Combivir
7. Azerbaijan Granted 5 million dollars in Fight Against Bird Flu
8. Rice University wins Prestigious Grants from HHMI
9. Developer Of Vaccine For Cancer Granted A Prestigious Fellowship
10. Indian, Chinese Students In France To Receive Grant From Thales
11. Lenalidomide, Granted Approval by FDA to Join Multiple Myeloma Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... Catalent ... for drugs, biologics and consumer health products, today announced that it had joined ... 2006 as a non-profit organization to unite pharmaceutical and healthcare companies that share ...
(Date:12/8/2016)... ... December 08, 2016 , ... STAT courier is pleased ... a convenient service for Texas, they are expanding their presence in Dallas. One of ... spree that will bring new jobs to the Dallas and Forth Worth market. STAT ...
(Date:12/8/2016)... ... 08, 2016 , ... Today’s patients are encouraged to be ... SIGVARIS has created a new line of anti-embolism stockings to help prevent a ... benefits of graduated compression when transitioning from recovery to early rehabilitation. , The ...
(Date:12/8/2016)... ... December 08, 2016 , ... Vida Health, the digital health ... led by Canvas Ventures . Other investors include Nokia Growth Partners (NGP) and ... to serve more consumers who are managing chronic conditions or simply want ...
(Date:12/8/2016)... ... December 08, 2016 , ... The ... from offices headquartered in Hamilton County, is embarking on a charity drive with ... in finding new homes for orphaned or neglected senior dogs in the Cincinnati ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , 8. Dezember 2016 Mederi Therapeutics Inc . hat die ... nicht-operative Behandlungsmethode für gastroösophageale Refluxerkrankung (GERD) – in China ... ... Live Stretta procedure performed ... Liu, Director of Endoscopy at Wuhan Union Hospital ...
(Date:12/8/2016)... 2016 Research and Markets has announced the ... offering. ... The global chromatography market to grow at a CAGR ... 2016-2020, has been prepared based on an in-depth market analysis with inputs ... prospects over the coming years. The report also includes a discussion of ...
(Date:12/8/2016)... ALBANY, New York , December 8, 2016 ... the global Diabetes Injection Pens Market is expected ... as compared to US$4.9 bn in 2015. Between the forecast ... to rise at a CAGR of 7.9%. The leading players ... Nordisk A/S, Eli Lilly and Company, AstraZaneca plc., Biocon Ltd., ...
Breaking Medicine Technology: